Tomasz Swierkosz, PhD
Cardiovascular Disease · Lawton, OKNPI 1386629111
Payments from drug & device makers
Across 23 payments — averaging $29.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$395
- Medtronic$115
- Novartis$43
- Abbott$24
- Inari Medical, Inc.$20
- E.r. Squibb & Sons, L.L.C.$20
- plus $55 from 4 others
What the payments were for
- Food & beverage$671100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 11 | $395 |
| Medtronic | 2 | $115 |
| Novartis | 3 | $43 |
| Abbott | 1 | $24 |
| Inari Medical, Inc. | 1 | $20 |
| E.r. Squibb & Sons, L.L.C. | 1 | $20 |
| Lundbeck LLC | 1 | $16 |
| Merck | 1 | $15 |
| La Jolla Pharmaceutical Company | 1 | $12 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $11 |
How this compares
$671 in reported general payments places this provider in the 20th percentile of 164 cardiovascular disease providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 66 | $70,859 |
| Losartan Potassium | 170 | $2,691 |
| Metoprolol Succinate | 120 | $2,467 |
| Atorvastatin Calcium | 112 | $1,386 |
| Lisinopril | 144 | $1,227 |
| ClopidogrelClopidogrel Bisulfate | 94 | $1,201 |
| Diltiazem 24hr ErDiltiazem Hcl | 17 | $963 |
| Metoprolol Tartrate | 109 | $857 |
| Carvedilol | 50 | $463 |
| Hydralazine Hcl | 16 | $446 |
| Nitroglycerin | 44 | $437 |
| Potassium Chloride | 24 | $278 |
| Amlodipine Besylate | 51 | $277 |
| Warfarin Sodium | 24 | $221 |
| Furosemide | 31 | $183 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Lawton
- Anderson MehrleBartlesville$1.6M
- Eric AuerbachTulsa$636K
- Nicholas HannaTulsa$446K
- Frank GaffneyTulsa$243K
- Stavros StavrakisOklahoma City$174K
- Ravi KodeTulsa$169K
- Gary DykstraBartlesville$122K
- Mark AndersonOklahoma City$113K
- David WilkettTulsa$104K
- Zainal HussainTulsa$101K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.